Suggestions
Brian Nahed MD, MSc. FCNS, FACS
Brain Tumor Surgeon and Program Director at Massachusetts General Hospital
Dr. Brian Nahed is a highly accomplished neurosurgeon and academic leader specializing in brain tumors. He currently serves as the Director of the MGH Neurosurgery Residency and is an Associate Professor in the Department of Neurosurgery at Massachusetts General Hospital and Harvard Medical School.1
Clinical Expertise
Dr. Nahed's clinical focus is on brain and spinal tumors, with particular expertise in:
- Glioblastoma
- Low-grade and high-grade gliomas
- Meningiomas
- Metastatic brain tumors
- Skull base surgery
He is renowned for his use of advanced intraoperative technologies like ultrasound and MRI to maximize tumor resection while ensuring patient safety.1
Academic and Leadership Roles
- Program Director of the MGH Neurosurgery Residency
- Associate Professor at Harvard Medical School
- Member of the Executive Committee for the Congress of Neurological Surgeons (CNS)
- Co-chair of the CNS Leadership Institute
- Executive committee member of the AANS/CNS Joint Section on Brain Tumors
- Neurotrauma consultant for the National Football League (NFL)12
Research
As a surgeon-scientist, Dr. Nahed leads a translational research program focused on developing blood-based tests for diagnosing and monitoring brain tumors. His work includes:
- Publishing the first evidence of circulating tumor cells in glioma patients' blood
- Leading an NIH-funded project on developing liquid biopsies for adult and pediatric brain tumors1
Education and Training
Dr. Nahed's educational background includes:
- Undergraduate degree from UCLA, graduating Phi Beta Kappa
- MD from Yale School of Medicine
- Neurosurgery residency at Massachusetts General Hospital
- Masters in Epidemiology from Harvard School of Public Health2
Dr. Nahed has authored over 100 peer-reviewed publications and contributes to clinical brain tumor guidelines for major neurosurgical organizations.2 His LinkedIn username is indeed briannahed.3
Highlights
Congratulations to the amazing 2024 Harvard Medical School DICP Research Investigators! A special shoutout to Mazen Tamen for his incredible work in developing a liquid biopsy for patients with brain tumors. Your dedication to advancing medical research is truly inspiring. Wishing Mazen a bright future ahead as a physician scientist! Huge thanks to the @HMS_DICP program for their unwavering support in shaping the next generation of investigators. Shannon Stott and I are so proud! @MassGenBrigham @MGHNeuroSci @harvardmed @MGBneurosurgery @MGHCancerCenter #HarvardMedicalSchool #MedicalResearch #PhysicianScientist #FutureLeaders
Truly game changing work developing CAR-T for brain tumor patients. So incredibly proud of the work of @MarcelaMaus @BryanDChoi @WTCNeuroscience providing incredible promise for our brain tumor patients. Establishing an incredible neuroimmunology program for brain tumor patients all over the world. #cantstopwontstop until there is a cure. https://lnkd.in/eura7PTY @MGHCancerCenter @MassGenBrigham @MGBneurosurgery
